Intuitive Surgical Expands Share Repurchase Program to $5.0 Billion, Approves Amended Incentive Plan
ISRG is trading near its 52-week low of $427.836 (5.7% above the low).
Summary
Intuitive Surgical's board authorized an additional $5.0 billion for its share repurchase program and stockholders approved an amended incentive plan allowing for 5,000,000 more shares for awards.
Key Events · Financing and Capital Events · ISRG
-
Share Repurchase Program Expanded
The Board of Directors increased the authorized amount for the common stock repurchase program to an aggregate of $5.0 billion, including amounts remaining under previous authorization. This follows the $1.13 billion share repurchase program detailed in the 10-Q filed on April 22, 2026. The program allows for repurchases from time to time, depending on market conditions, and will be funded through cash, cash equivalents, and investments.
-
Amended Incentive Award Plan Approved
Stockholders approved the amendment and restatement of the 2010 Incentive Award Plan, increasing the number of shares reserved for issuance by 5,000,000, from 120,350,000 to 125,350,000. If all authorized shares were issued, this would result in potential dilution of approximately 1.41% based on current outstanding shares. The plan also extends its term to January 29, 2036, and specifies treatment of awards in connection with a change in control.
-
Annual Meeting Results
At the Annual Meeting held on April 30, 2026, stockholders elected ten directors, approved the compensation of Named Executive Officers on an advisory basis, and ratified the appointment of PricewaterhouseCoopers LLP as the independent registered public accounting firm for fiscal year 2026. All proposals passed as described in the proxy statement filed on March 13, 2026.
Analysis · ISRG · Industrial Applications And Services
Intuitive Surgical's Board of Directors significantly increased the company's share repurchase authorization to an aggregate of $5.0 billion. This substantial capital allocation decision, following a previous $1.13 billion authorization noted in the recent 10-Q, signals strong financial health and a commitment to returning value to shareholders. Additionally, stockholders approved an amendment to the 2010 Incentive Award Plan, authorizing the issuance of up to 5,000,000 additional shares for employee compensation, which represents a moderate potential for dilution.
At the time of this filing, ISRG was trading at $452.35 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $160.2B. The 52-week trading range was $427.84 to $603.88. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.